Abstract 294P
Background
Cancer patients are living longer with early detection and improved treatment. When combined with conventional therapy, complementary and alternative medicine (CAM) might help patients manage cancer symptoms and treatment toxicities. Ayurveda, Yoga Naturopathy, Unani, Siddha, and Homeopathy (AYUSH) are native to India, and widely practiced, yet, their association with cancer-related distress is unknown.
Methods
From March to June 2022, cancer patients attending OPD, IPD, and Daycare services at AIIMS Rishikesh responded to a patient health questionnaire (PHQ-9), along with a locally developed and validated questionnaire about knowledge, attitude, practices (KAP) of CAM. Bivariate and multivariate analyses were performed to ascertain the levels of depression/distress, KAP-related outcomes of CAM among cancer patients.
Results
556 cancer patients with a mean age of 48.59 ± 14.82 years (286 males, 270 females) were included. 393 respondents (70.7%) had never used CAM, while 163 (29.3%) had. 342 (61.5%) participants said they would choose CAM if their condition became untreatable, 129 (23.2%) wouldn't, 85 (15.3%) were not sure. Use of CAM was correlated with cancer stage (C 0.104, p 0.045) (ρ .098, p .020). Individuals with stage 4 cancer were more likely to have used CAM (p .029, OR 1.719, CI 1.059 ± 2.792). Multinomial linear regression showed that metastatic cancer tends to have more severe depression (p .022, OR 3.900, CI 1.218 ± 12.490). The level of education was inversely related to beliefs about CAM's effectiveness in curing cancer (C .185, p .012 & ρ -0.12, p .004) and its safety with fewer adverse reactions than modern medicine (C .197, p .004 & ρ -.124, p .003). Among AYUSH modalities, 212 (38.1%) chose Yoga, 186 (33.5%) Ayurveda, 45 (8.1%), Unani, 19 (3.4%), Siddha, and 173 (31.1%) chose others.
Conclusions
Terminally ill patients used CAM more, advanced-stage cancer patients had higher depression scores. People with lower educational status believe in CAM more.Yoga was the most preferred CAM. CAM can aid in improving cancer therapy tolerance and end-of-life care but specific CAM especially yoga protocols can be developed to help in these situations.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
314P - Let’s bring back old drugs to conquer resistance to KRAS G12C inhibitors in NSCLC
Presenter: Anisha Jain
Session: Poster viewing 04
315P - Molecular testing in lung squamous cell carcinoma using DNA- and RNA-based next-generation sequencing: A single-center experience
Presenter: Luka Brcic
Session: Poster viewing 04
316P - Phase II study of ramucirumab and docetaxel for platinum-resistance NSCLC patients with malignant pleural effusion: Analysis of pleural effusion control rate
Presenter: Ryosuke Ogata
Session: Poster viewing 04
317P - A project to investigate the actual status of biomarker testing in unresectable advanced or recurrent non-small cell lung cancer: WJOG15421 L (REVEAL)
Presenter: Taichi Matsubara
Session: Poster viewing 04